Sarepta Therapeutics Cash Flow Statement (2010-2025) | SRPT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-167.25M	-81.41M	-48.14M	249.33M	-105.03M	-231.48M	-257.74M	142.14M	-516.71M	-23.94M	-40.94M	326.93M	36.12M	6.48M	33.61M	158.76M	-447.51M	196.94M	-179.95M	352.82M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	28.50M	28.97M	26.68M	29.78M	29.20M	102.89M	50.42M	50.51M	41.30M	47.40M	48.10M	45.81M	40.70M	55.65M	49.00M	70.53M	41.43M	37.00M	14.90M	-93.39M
Gains from Sales and Divestitures (Quarter)				0.28M				0.39M		0.39M		0.64M		0.04M	0.10M	0.04M		0.04M	0.04M	0.03M
Gains from Investment Securities (Quarter)	-2.69M	18.00	4.50M	-13.67M	0.71M	0.15M	0.07M	0.34M	1.08M	1.11M		0.36M	0.28M	-5.17M	0.14M	36.79M	1.50M	1.82M	3.50M	-36.93M
Non-cash Items (Quarter)				248.48M				4.69M				288.12M				6.27M				0.40M
Cash from Operations (Quarter)	-180.37M	-109.15M	-124.33M	-29.33M	-101.17M	-66.81M	-64.96M	-92.39M	-209.40M	-122.23M	-114.71M	-54.66M	-242.08M	14.94M	-70.70M	92.05M	-583.44M	261.34M	-14.59M	131.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)					-0.05M	-1.41M	-3.06M	-6.13M	-8.65M	-11.59M	-12.60M	-13.33M	-12.40M	-10.46M	-10.62M	-6.80M	-1.91M	-1.87M	-1.13M	-0.38M
Depreciation & Amortization (CF) (Quarter)	8.93M	8.45M	10.49M	10.14M	10.72M	9.89M	10.70M	10.55M	11.30M	10.79M	10.93M	11.37M	8.74M	8.72M	9.81M	10.46M	9.98M	10.84M	18.45M	5.25M
Change in Working Capital
Change in Receivables (Quarter)	16.86M	9.32M	22.27M	3.20M	25.20M	25.66M	-2.35M	13.12M	9.21M	12.97M	82.05M	81.47M	-21.52M	-18.81M	74.53M	167.46M	57.38M	-132.08M	-131.56M	2.49M
Change in Inventory (Quarter)	8.37M	28.42M	19.71M	27.26M	4.69M	10.68M	26.54M	8.88M	0.31M	26.69M	26.61M	94.10M	60.51M	102.46M	70.54M	161.66M	177.36M	59.19M	83.02M	-18.48M
Change in Accured Expenses (Quarter)	-44.96M	51.41M	-52.96M	69.81M	-5.02M	86.52M	53.20M	12.88M	-67.54M	-26.13M	-17.55M	61.09M	-92.84M	77.59M	1.69M	124.21M	-17.71M	-24.47M	-103.17M	249.62M
Other Working Capital Changes (Quarter)	-34.91M	-9.34M	-22.50M	-36.45M	-22.00M	-22.25M	9.86M	62.34M	-22.00M	12.37M	-57.11M	-20.08M	2.31M	-42.70M	79.76M	-71.54M	-85.40M	25.57M	159.90M	-20.29M
Investing Activities
Capital Expenditures (Quarter)	21.15M	5.89M	9.24M	2.21M	5.55M	9.08M	8.23M	7.96M	9.48M	17.91M	29.67M	19.04M	32.44M	29.17M	37.26M	38.08M	43.65M	31.80M	22.93M	3.59M
Change in Intangibles (Quarter)				-99.69M					0.09M	0.04M	101.86M		10.00M			-10.00M	2.24M	0.19M	5.31M	0.14M
Change in Acquisitions & Divestments (Quarter)	210.00M	226.00M	30.00M			77.15M	399.57M	446.50M	448.83M	415.62M	475.81M	528.22M	477.69M	261.47M	297.84M	965.11M	40.76M	68.63M	86.55M	99.94M
Cash from Investing Activities (Quarter)	156.67M	321.06M	20.27M	-2.58M	-785.81M	-289.99M	19.12M	9.80M	12.49M	96.63M	-210.57M	-64.36M	218.80M	-98.53M	-128.82M	764.12M	-291.18M	32.21M	232.40M	96.21M
Financing Activities
Other financing activities (Quarter)		1.43M						0.55M												0.11M
Cash from Financing Activities (Quarter)	2.89M	3.53M	5.90M	549.25M	4.99M	0.34M	216.43M	10.75M	101.80M	5.86M	15.40M	1.94M	22.14M	39.92M	13.76M	48.99M	12.47M	-23.82M	-117.79M	-39.21M
Additional items
Change in Cash (Quarter)	-20.81M	215.44M	-98.16M	517.35M	-881.99M	-356.47M	170.58M	-71.85M	-95.11M	-19.74M	-309.87M	-117.07M	-1.14M	-43.67M	-185.77M	905.15M	-862.14M	269.73M	100.03M	188.21M
Free Cash Flow (Quarter)	-201.52M	-115.04M	-133.57M	-31.53M	-106.73M	-75.89M	-73.19M	-100.36M	-218.88M	-140.14M	-144.38M	-73.70M	-274.52M	-14.22M	-107.96M	53.96M	-627.09M	229.54M	-37.52M	127.61M
Net Cash Flow (Quarter)	-20.81M	215.44M	-98.16M	517.35M	-881.99M	-356.47M	170.58M	-71.85M	-95.11M	-19.74M	-309.87M	-117.07M	-1.14M	-43.67M	-185.77M	905.15M	-862.14M	269.73M	100.03M	188.21M

Research Tools

Sarepta Therapeutics Cash Flow Statement (2010-2025) | SRPT

Create an account

Sign In

Reset Password